These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


93 related items for PubMed ID: 9690075

  • 1. [The efficacy of Kvamatel and Omez in correcting disorders of the antioxidant system of the digestive tract organs in experimental duodenal ulcer].
    Karimov KhIa, Khakimov ZZ, Daminov ShN.
    Eksp Klin Farmakol; 1998; 61(3):38-40. PubMed ID: 9690075
    [Abstract] [Full Text] [Related]

  • 2. [A comparative evaluation of the action of kvamatel and omez on the glutathione system in different sections of the digestive system in experimental duodenal ulcer].
    Daminov ShN, Inoiatova FKh.
    Eksp Klin Farmakol; 1998; 61(4):26-8. PubMed ID: 9783104
    [Abstract] [Full Text] [Related]

  • 3. [The effect of perftoran on the morphofunctional status of the digestive system organs in experimental duodenal ulcer].
    Karimov KhIa, Daminov ShN, Khoroshaev VA.
    Eksp Klin Farmakol; 1999; 62(4):33-6. PubMed ID: 10513333
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Comparative assessment of the strength properties of the mucous membrane of the stomach in patients with peptic ulcer and the effect of quamatel on ulcer cicatrization in experiment].
    Ias'kov IM, Troshin VP, Kirillov SK, Korolev AA, Martynovich AI.
    Med Tekh; 2008; (1):6-8. PubMed ID: 18354903
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Clinical aspects of Kvamatel (famotidine) administration].
    Golochevskaia VS.
    Klin Med (Mosk); 1996; 74(1):45-7. PubMed ID: 8649009
    [No Abstract] [Full Text] [Related]

  • 15. Non-steroidal anti-inflammatory drug gastropathy: clinical results with H2 antagonists and proton pump inhibitors.
    Lazzaroni M, Bianchi Porro G.
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S73-8. PubMed ID: 10379473
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial.
    Kantorova I, Svoboda P, Scheer P, Doubek J, Rehorkova D, Bosakova H, Ochmann J.
    Hepatogastroenterology; 2004; 51(57):757-61. PubMed ID: 15143910
    [Abstract] [Full Text] [Related]

  • 19. [Prevention of ulcer lesions under non-steroid antirheumatic agents. For each patient the appropriate stomach protection].
    MMW Fortschr Med; 2004 May 27; 146(22):48. PubMed ID: 15373113
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection.
    Murakami K, Okimoto T, Kodama M, Sato R, Miyajima H, Ono M, Inoue K, Watanabe K, Otsu S, Fujioka T.
    Helicobacter; 2006 Oct 27; 11(5):436-40. PubMed ID: 16961805
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.